Carna
Boston, US · Founded 2021 · Delaware corporation
Biotech
Founders & leadership
JN
Justin NguyenExecutive
FR
Faisal RushoExecutive
SV
Salvatore ViscomiNamed on SEC filing
JP
Jose PereyraNamed on SEC filing
BB
Boris BeratNamed on SEC filing
Board
ML
Michelle LongmireBoard director
Reported raises · per SEC filings
Form D private placements$9.1M disclosed across 1 round · 2025
▶$9.1MraisedJun 2026 · 27 investors · BiotechnologyRule 506(b)
▶$9.1MraisedJun 2026 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Salvatore ViscomiExecutive Officer, Director, Promoter
- Justin NguyenExecutive Officer
- Juan MarichalPromoter
- Jose PereyraDirector, Promoter
- Faisal RushoExecutive Officer
- Boris BeratExecutive Officer, Director, Promoter
- David VogelPromoter
- Michelle LongmireDirector
- Offering amount
- $10M
- Amount sold
- $9.1M
- Proceeds to insiders
- $1.4M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Carna raised?
- Carna has disclosed $9.1M raised across 1 round.
- Where is Carna headquartered?
- Carna is headquartered in Boston, US.